Cargando…
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
Antipsychotic-induced weight gain is a major management problem for clinicians. It has been shown that weight gain and obesity lead to increased cardiovascular and cerebrovascular morbidity and mortality, reduced quality of life and poor drug compliance. This narrative review discusses the propensit...
Autores principales: | Dayabandara, Madhubhashinee, Hanwella, Raveen, Ratnatunga, Suhashini, Seneviratne, Sudarshi, Suraweera, Chathurie, de Silva, Varuni A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574691/ https://www.ncbi.nlm.nih.gov/pubmed/28883731 http://dx.doi.org/10.2147/NDT.S113099 |
Ejemplares similares
-
Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis
por: de Silva, Varuni Asanka, et al.
Publicado: (2016) -
Use of lithium in clozapine-induced neutropenia: a case report
por: Suraweera, Chathurie, et al.
Publicado: (2014) -
Phagophobia: a case report
por: Suraweera, Chathurie, et al.
Publicado: (2014) -
Simvastatin-induced cognitive dysfunction: two case reports
por: Suraweera, Chathurie, et al.
Publicado: (2016) -
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
por: Wijesundera, Hiranya, et al.
Publicado: (2014)